Alexion Pharmaceuticals, Inc. (ALXN)

SapphireSeas (77.20) Submitted: 10/04/07 1:42 PM : Start Price: $34.35 ALXN Score: 41.59

Reuters, 10/4/07:

In a departure from the current status quo, Presidential front runner Senator Hillary Clinton would support stem cell funding and research.

That would be a boon for research efforts and for companies such as ALXN, which specializes in the development of biologic therapeutic products for the treatment of hematologic and cardiovascular disorders, auto-immune diseases, and cancer.

Alexion stock has endured negative earnings, and the P/S is 147. Any change in official policy could put this company and stock on a rocket ride to the moon. Buy and hold long.

Report this Post Replies: 0 | Reply | Permalink